Maternal Hypertension Clinical Trial
Official title:
An Observational Study of Perinatal Outcomes Following Change in Clinical Criteria in for Treatment of Maternal Hypertension
The purpose of this study is observe outcomes before and after a change in clinical practice in the threshold for management of severe hypertension in pregnancy and the post-partum period. Outcomes will be observed for 10 months under the current (traditional) clinical blood pressure threshold for acute treatment of hypertension, which is >= 160 millimeters of mercury (mmHg) systolic blood pressure (SBP). This will be followed by one month of education about rationale for the new SBP threshold of >= 180 mmHg and change of clinical guidelines. Then, there will be 10 months of observation after adopting the updated clinical threshold for acute antihypertensive treatment (>= 180 SBP).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05726279 -
PROtecting Maternal Brains From Injury and Stroke
|
N/A | |
Not yet recruiting |
NCT06344702 -
The Effect of CPAP on Maternal and Infant Outcomes in Pregnant Women With OSAS
|
||
Recruiting |
NCT04766866 -
sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.
|
N/A | |
Recruiting |
NCT05551104 -
Safest Choice of Antihypertensive Regimen for Postpartum Hypertension
|
Phase 3 |